# Goldman Sachs Alternatives' Life Sciences team: portfolio, investments and team > Goldman Sachs Alternatives' Life Sciences team is a growth equity. 1 investment on record, 1 in the last 12 months, latest Apr 2026. Source: https://millionrounds.com/fund/goldman-sachs-alternatives-life-sciences-team (Millionrounds; every figure on the page links to its filing or article) [Investor](https://millionrounds.com/investors) # Goldman Sachs Alternatives' Life Sciences team Last cheque observed Apr 2026; 1 cheques on record. Email Growth equity Deploying now Series B Follow Goldman Sachs Alternatives' Life Sciences team and see its new cheques in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Ffund%2Fgoldman-sachs-alternatives-life-sciences-team) Deploying now **100%** of best year **1** **cheques in 12 months**, 1 on record Since the last cheque **221** days **00** hrs **00** min **00** sec Median round **$137M** Rounds led **0 of 1** Pitch Goldman Sachs Alternatives' Life Sciences team ## Goldman Sachs Alternatives' Life Sciences team highlights - 01 1 cheques in the last 12 months - 02 Mostly Series B: 100% of its rounds ## What they do - **Type:** Growth equity (from a list, unverified) - **Cheque size:** Not stated - **Cold pitches:** Not stated ## The record Every round we can evidence, newest first **1 appearances** - **2026** 1 round - **Apr** **[Sidewinder Therapeutics](https://millionrounds.com/company/sidewinder-therapeutics)** Series B · US · Ventureburn **$137M** With 8 others An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor. ## The cheque Series B Median round joined **$137M** the round, not its cheque Led 0 of 1 rounds **0%** - **Sole investor:** Never alone - **Last cheque:** Apr 2026 Rounds by stage said on their site - Series B *1* Cheques by month Led Joined Dec 2023 Nov 2026 **Pitching Goldman Sachs Alternatives' Life Sciences team?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque. Add to your CRM *→* ## Recently backed The latest companies Goldman Sachs Alternatives' Life Sciences team put money into. [**Sidewinder Therapeutics** $137M · Apr 2026](https://millionrounds.com/company/sidewinder-therapeutics) ## Quick answers about Goldman Sachs Alternatives' Life Sciences team ### What does Goldman Sachs Alternatives' Life Sciences team invest in? Goldman Sachs Alternatives' Life Sciences team invests most often at Series B (100% of the rounds on record). ### How active is Goldman Sachs Alternatives' Life Sciences team? 1 investments on record, 1 of them in the last 12 months. The most recent was in Apr 2026. ### What has Goldman Sachs Alternatives' Life Sciences team invested in recently? Its most recent investments on record: Sidewinder Therapeutics (Series B, Apr 2026). ### How big are Goldman Sachs Alternatives' Life Sciences team's cheques? The median round it joins is $137M. ### Is Goldman Sachs Alternatives' Life Sciences team investing now? Yes: it is actively investing, with 1 investments in the last 12 months. ### What kind of investor is Goldman Sachs Alternatives' Life Sciences team? Goldman Sachs Alternatives' Life Sciences team is a growth equity firm. ### Where does this information on Goldman Sachs Alternatives' Life Sciences team come from? From 1 articles and filings naming it in a round, public registers and its own website, checked and rebuilt every night. ## Raising now? Find the investors who back rounds like yours, and keep every conversation on one fundraising board. Find similar investorsOpen your CRM Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=goldman-sachs-alternatives-life-sciences-team) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=goldman-sachs-alternatives-life-sciences-team)